Suppr超能文献

研究一种替代方法,使用 4-硫酸化 N-乙酰半乳糖胺更有效地靶向巨噬细胞上的甘露糖受体,与甘露糖修饰的脂质体相比:在药物输送中的应用。

Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery.

机构信息

Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow, India.

出版信息

Nanomedicine. 2012 May;8(4):468-77. doi: 10.1016/j.nano.2011.07.002. Epub 2011 Jul 23.

Abstract

UNLABELLED

In this study the potential of 2 different ligands, i.e., palmitoyl mannose (Man-Lip) and 4-SO(4)GalNAc (Sulf-Lip) to target resident macrophages was investigated after surface decoration of Amphotericin B (AmB) loaded liposomes. In the case of Sulf-Lip, the 4-SO(4)GalNAc was adsorbed through electrostatic interaction on cationic liposomes, which was confirmed by change in zeta potential from +48.2 ± 3.7 mV for Lip to +12.2 ± 1.3 mV for Sulf-Lip. The mean particle size of Sulf-Lip and Man-Lip was found to be 139.4 ± 7.4 nm and 147.4 ± 8.6 nm, respectively. Flow cytometric data reveal enhanced uptake of Sulf-Lip in both J774 and RAW cell lines in comparison with the uptake of Man-Lip. Intracellular localization studies indicate that the fluorescence intensity of Sulf-Lip was much higher in comparison with that of Man-Lip and Lip formulations. Sulf-Lip and Man-Lip showed significantly higher localization of AmB at all time points in comparison with Lip (P < 0.05) after intravenous (IV) administration. The studies provide evidence that 4-SO(4)GalNAc possesses a promising feature for targeting resident macrophages and its application in the conditions of leishmaniasis is in the offing.

FROM THE CLINICAL EDITOR

This in vivo study compares two different ligands to deliver Amphotericin B l(AmB) loaded liposomes to resident macrophages. Targeted approaches showed significantly higher localization of AmB at all time points in comparison to non-targeted liposomes, and future applications in leishmaniasis are already under preparation.

摘要

未加标签

在这项研究中,研究了两种不同配体,即棕榈酰甘露糖(Man-Lip)和 4-SO(4)GalNAc(Sulf-Lip),在阿霉素(AmB)负载脂质体表面修饰后,将其靶向驻留巨噬细胞的潜力。在 Sulf-Lip 的情况下,4-SO(4)GalNAc 通过静电相互作用吸附在阳离子脂质体上,这从脂质体的 ζ 电位从+48.2±3.7 mV 变为+12.2±1.3 mV 得到证实。Sulf-Lip 和 Man-Lip 的平均粒径分别为 139.4±7.4nm 和 147.4±8.6nm。流式细胞术数据显示,与 Man-Lip 相比,Sulf-Lip 在 J774 和 RAW 细胞系中的摄取量增加。细胞内定位研究表明,与 Man-Lip 和 Lip 制剂相比,Sulf-Lip 的荧光强度要高得多。与 Lip 相比,Sulf-Lip 和 Man-Lip 在静脉注射(IV)给药后所有时间点的 AmB 定位明显更高(P<0.05)。这些研究表明,4-SO(4)GalNAc 具有靶向驻留巨噬细胞的有前途的特征,并且它在利什曼病的应用即将到来。

临床编辑

本体内研究比较了两种不同的配体,将阿霉素(AmB)负载的脂质体递送至驻留巨噬细胞。与非靶向脂质体相比,靶向方法在所有时间点均显示出更高的 AmB 定位,并且已经在准备将其应用于利什曼病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验